Table 3 Summary of treatments

Triple therapy

 P + A + C

(Low resistance of C)

Canada, Indonesia, ACG, ASEAN, Egypt, Korea, India, Maastricht VI, Italy, WGO, Belgium, Africa, Ireland

13/24

Brazil, Germany, Ireland

3/23

 P + A + C

Latin America, Japan, Brazil, Malaysia

4/24

 P + C + M

(Low resistance of C)

Thailand^a, Canada, WGO^a

3/24

/

/

 P + C + M

Latin America, Japan^a, India^a, Malaysia^a

5/24

 P + A + M

Canada, Japan, ASEAN, Korea

4/24

India

1/23

 P + A + L

(Low resistance of L)

Latin America, ASEAN

3/24

Latin America, Thailand, Canada, ACG, Brazil, Egypt, Korea, Greece, India, Maastricht VI, Italy, Malaysia, WGO, Africa, Germany

16/23

 P + A + R

ACG

/

Canada, ACG, ASEAN, Korea, Greece, India, Maastricht VI, Italy, WGO, Belgium, Ireland, Indonesia

11/23

 P + A + Ti

Canada, ASEAN

2/24

/

/

 P + C + L

Brazil^a, Greece^a

2/24

India^a

1/23

 P + A + S

/

/

Japan, Korea

2/23

 P + A + Mo

/

/

Korea, Greece, India

3/23

Bismuth-based quadruple therapy

 P + B + M + T

Thailand^a, Canada^a, Indonesia^a, Ireland, ACG^a, ASEAN^a, Brazil^a, Korea^a, Spanish^a, India^a, Maastricht VI^a, China^a, Saudi^a, Vietnam, Malaysia, WGO^a, Belgium^a, Germany

18/24

Thailand, Canada, Ireland, ACG, Brazil, Egypt, Korea, Spanish^a, India, Greece^a, Saudi, Vietnam, WGO, Africa

14/23

 P + B + A + M

ASEAN, China

2/24

/

/

 P + B + A + T

India, China

2/24

/

/

 P + B + A + L

China, Vietnam

2/24

ASEAN, Brazil, Korea, Spanish, India, Maastricht VI, Vietnam, Africa, Ireland

9/23

 P + B + C + L

China^a

1/24

Spanish^a

1/23

Concomitant quadruple therapy

 P + A + C + M

Latin America, Thailand, Canada, ASEAN, Brazil, Korea, Spanish, Greece, Maastricht VI, Saudi, WGO, Belgium, Indonesia

12/24

Latin America, Korea, Spanish

3/23

 P + A + C + Ni

Saudi

2/24

Egypt

2/23

 P + A + C + Ti

Latin America, ASEAN, Brazil, Saudi, Italy

5/24

Latin America, Italy

2/23

Sequential therapy

 P + A/P + C + M

Latin America, Thailand, Korea, India

4/24

/

/

 P + A/P + A + C + M

ASEAN, Greece, Africa

3/24

/

/

 P + A/P + C + Ti

Latin America, Italy

2/24

Italy

1/23

High-dose therapy

 P + A

China, Malaysia

2/24

Japan, ACG 2017, ASEAN, Korea, Maastricht VI, Italy, Malaysia, WGO, Indonesia

8/23